Protein kinase CK2 is an ubiquitous and pleiotropic Ser/ Thr protein kinase composed of two catalytic (a and/or a') and two regulatory (b) subunits generally combined to form a 2 b 2 , aa'b 2 , or a' 2 b 2 heterotetramers. To gain more insight into the role of CK2 in the control of proliferation in mammalian cells, overexpression of isolated CK2 subunits a, a', or b was carried out in two ®broblast cell lines: NIH3T3 and CCL39. To interfere with CK2 cellular functions, cells were also transfected with a kinase-inactive mutant of CK2a catalytic subunit: CK2a-K68A. In NIH3T3 cells, overexpression of either wild-type subunit (a, a' or b) had no eect on cell proliferation. In contrast, overexpression of the CK2a kinase-de®cient mutant induced a marked inhibition of cell proliferation. This resulted from a defect in G1/S progression as demonstrated in transient transfection experiments in both NIH3T3 and CCL39 cells using BrdU incorporation measurements and in CCL39 clones stably overexpressing the CK2a-K68A mutant by growth curve analysis. We demonstrated that the kinase-negative mutant has the capacity to integrate the endogenous CK2 subunit pool both as an isolated kinase-inactive a subunit and as associated to the b subunit in a kinase-inactive tetramer. Finally we showed that expression of the kinase-inactive mutant interferes with phosphorylation of an endogenous CK2 substrate; we speculate that optimal phosphorylation of target proteins by CK2 is required to achieve optimal cell cycle progression.
Introduction
Protein kinase CK2 (formerly casein kinase II) is a highly conserved Ser/Thr protein kinase ubiquitously distributed among eukaryotic organisms. It is a highly pleiotropic enzyme: the non exhaustive list of the in vitro substrates of CK2 identi®ed to date includes more than 160 proteins involved in a wide variety of cellular functions such as control of metabolism, gene expression, protein synthesis, cell division and proliferation (Allende and Allende, 1995; Pinna and Meggio, 1997) . The holoenzyme that has been puri®ed from many dierent eukaryotes is generally a heterotetramer composed of catalytic (a, a') and regulatory (b) subunits combined to form a 2 b 2 , aa'b 2 , or a' 2 b 2 heterotetramers. The a and a' subunits are catalytically active, whereas the b subunit is inactive but appears to play an important regulatory role towards the catalytic subunits: it stimulates the activity of a and a' subunits towards most of the substrates (Pinna and Meggio, 1997) and can also facilitate substrate recognition. However, a number of recent results suggest that a fraction of CK2a might exist free of CK2b. Naturally monomeric forms of CK2a have been isolated from Zea mays (Dobrowolska et al., 1992) and Dictyostelium discoideum (Kikkawa et al., 1992) where no protein equivalent of CK2b has yet been found. Functional evidence also argues in favor of the existence of isolated CK2a or b subunits: phosphorylation of certain substrates such as calmodulin by CK2a is in fact inhibited by CK2b (Bidwai et al., 1993; Meggio et al., 1994) ; in Xenopus oocytes, the eect of CK2b on Mos-mediated cascade is inhibited by the presence of CK2a (Chen et al., 1997) ; a population of CK2a that binds to PP2A is free of CK2b (Heriche et al., 1997) .
Although CK2 was one of the ®rst protein kinases discovered and has been studied for over 40 years, both its mechanism of regulation and its physiological role remain poorly understood. Crystal structure of the catalytic subunit a has con®rmed the constitutively active nature of CK2 (Nie®nd et al., 1998) ; CK2 is not known to respond to any second messenger.
The physiological role of CK2 has been explored using genetic approaches in Saccharomyces cerevisiae (Padmanabha et al., 1990) , Schizosaccharomyces pombe (Snell and Nurse, 1994) , and Dictyostelium discoideum (Kikkawa et al., 1992) . In S. cerevisiae, the simultaneous disruption of the two catalytic subunit genes CKA1 and CKA2 is lethal, demonstrating that CK2 is essential for viability. Using temperature-sensitive mutants, Glover and colleagues also demonstrated that CK2 is required for cell cycle progression in both G1 and G2/M phases of the cell cycle (Hanna et al., 1995) .
The role of CK2 in mammalian cells has been examined by manipulating the expression of the dierent subunits using various techniques. Although these studies suggest that the enzyme is involved in cell proliferation and transformation, there are discrepancies concerning the precise role of CK2 in these processes. The targeted expression of CK2a in the T cells of transgenic mice caused a high predisposition for lymphoma formation and coexpression with c-Myc resulted in the rapid development of leukemia (Seldin and Leder, 1995) . CK2 contributes to the transformation of primary and established ®broblasts: overexpression of either catalytic subunit CK2 a or a' synergizes with Ras in the transformation of rat embryo ®broblasts and Balb/c 3T3 cells (Orlandini et al., 1998) . In contrast, overexpression of CK2a inhibits Ras-dependent transformation of NIH3T3 ®broblasts (Heriche et al., 1997) . Microinjection of antibodies directed against either the catalytic a, a' or the regulatory b subunits inhibits cell cycle progression in response to serum in human IMR-90 ®broblasts (Lorenz et al., 1999 (Lorenz et al., , 1993 Pepperkok et al., 1994) . CK2 antisense treatment inhibits cell proliferation (Pepperkok et al., 1991) and blocks neuritogenesis in neuroblastoma cells (Ulloa et al., 1993) . Induction of a kinase-inactive mutant of CK2a' in an osteosarcoma cell line signi®cantly inhibits cell growth but has no eect on cell cycle (Vilk et al., 1999) . Finally, the expression of CK2b induces severe defects in cell growth of Chinese hamster ovary cells and 3T3 L1 ®broblasts (Li et al., 1999) .
In the present study, we have analysed the eect of transient or stable overexpression of wild-type or mutated CK2 isolated subunits in two ®broblast cell lines: NIH3T3 and CCL39. We demonstrate in both cell lines that whereas overexpression of wild-type CK2 a, a' or b subunits has no detectable eect on cell proliferation, overexpression of a kinase-inactive mutant of CK2a: CK2a-K68A results in a severe impairment in proliferation that appears to be linked to defects in G1/S progression.
Results
Overexpression of CK2 a, a' or b subunits does not affect NIH3T3 fibroblast proliferation NIH3T3 ®broblasts were transiently transfected with the plasmids encoding each CK2 subunit alone: pSG5/CK2a, pSG5/CK2a', or pSG5/CK2b. The empty vector (pSG5) was used as a control. The transfection procedure used was the calcium phosphate coprecipitation. Overexpression of CK2 subunits was detected by immunoblotting using antiCK2a and anti-CK2b polyclonal rabbit antisera ( Figure 1A ) and by kinase assays ( Figure 1B ). As illustrated in Figure 1A , appreciable and comparable high levels of expression were obtained with the calcium phosphate transfection procedure for each CK2 subunit. Transient overexpression of any of the CK2 subunits did not aect the endogenous expression of the other subunits.
To examine whether the overexpressed catalytic a and a' subunits were enzymatically active, the CK2 activities in lysates from cells transfected with a or a' CK2 subunits were determined using a speci®c substrate for CK2: the synthetic peptide RRRE-DEESDDEE. In cells transfected with the empty vector, a basal level of activity corresponding to endogenous constitutive CK2 activity was detected. No increase in CK2 activity was detected in cells transfected with pSG5/CK2b; in contrast, cells transfected with either catalytic subunit (pSG5/CK2a or pSG5/CK2a') exhibited a comparable much higher CK2 activity than cells transfected with pSG5 vector alone ( Figure 1B ) (10 ± 20-fold increase according to the transfection eciency).
To analyse whether overexpression of a, a' or b CK2 subunits interferes with cell cycle progression, we monitored DNA replication by measuring BrdU incorporation (detected by double immuno¯uores-cence) in NIH3T3 cells transiently transfected with CK2 a, a' or b subunit. For these experiments, cotransfection of the Green Fluorescent Protein was used as a marker to identify transfected cells ± GFP appears not to interfere with cell growth and function ± (Zeng et al., 1997) .
We ®rst examined whether CK2 a, a' or b subunit overexpression interferes with G1/S progression: for this purpose, we monitored DNA replication in cells stimulated with serum for reentry into the cell cycle after synchronization by serum-deprivation. The percentage of BrdU(+) / GFP(+) cells represents the fraction of GFP (+) cells with active DNA synthesis. As shown in Figure 1c , overexpression of CK2 a, a' or b had no eect on BrdU incorporation since the percentage of BrdU (+) / GFP (+) cells in these conditions was similar to that measured in control cells transfected with empty vector. As a positive control, we used expression of a protein known to interfere with proliferation: the MAPK phosphatase Pyst-1 (MKP-3) (Groom et al., 1996) . As expected, blockade of p42/p44 MAPK signalling by expression of Pyst-1 inhibited progression into S phase (70% inhibition).
To detect a possible eect of CK2 on later phases of the cell cycle we did the same type of experiments on a population of asynchronous cycling cells. In these conditions, as observed in the case of synchronized cells stimulated for cell cycle reentry, expression of MKP-3 signi®cantly inhibited BrdU incorporation whereas overexpression of either CK2 subunit had no detectable eect (data not shown).
We conclude from these results that overexpression of either catalytic (a or a') or regulatory (b) subunit of CK2 does not interfere with cell cycle progression in NIH3T3 ®broblasts.
Effect of the CK2a kinase-negative mutant expression on cellular CK2 activity Dominant-negative mutants have proven very useful tools in de®ning the role of components in signal transduction cascades (Herskowitz, 1987) . We investiOncogene A dominant-negative mutant of CK2 inhibits cell proliferation F Lebrin et al gated the eect of a kinase-inactive mutant of CK2 a catalytic subunit on cell proliferation postulating that this mutant could exert a dominant-negative behaviour on CK2 functions. A lysine residue considered as essential for the phosphotransfer reaction and conserved in all kinases identi®ed so far (Hanks and Hunter, 1995) : Lys 68 (kinase subdomain II) was mutated to an alanine residue. This CK2a-K68A (CK2aK
7
) mutant had no catalytic activity in vitro (data not shown). To check that the a-K68A mutant was still inactive when expressed in the cells, we used transfection of HA-tagged CK2a and CK2a-K68A plasmids to perform anti-HA (12CA5) immunoprecipitation experiments followed by kinase assays. High levels of overexpression were obtained for both CK2a-HA and CK2a-K68A-HA proteins in NIH3T3 cells (Figure 2A ) whereas no eect on expression of CK2b was detected. As shown in Figure 2B , kinase activity was undetectable in 12CA5 immunoprecipitates from cells transfected with the empty vector pSG5. As expected, much higher levels of CK2 activity were observed in 12CA5 immunoprecipitates from cells expressing CK2a-HA than from cells expressing the kinase-de®cient mutant (13.5-fold ratio). The weak activity detected in the latter immunoprecipitates probably results from the formation of complexes containing both exogenous kinase-inactive CK2a and endogenous active CK2a. These results con®rm previous ®ndings obtained with dierent kinase-de®cient mutants of CK2 a expressed in Cos-7 cells: CK2a-K68M (Penner et al., 1997) ; CK2a-Asp 156 Ala (Korn et al., 1999) .
To analyse whether overexpression of the a-K68A mutant had a global eect on CK2 activity, we performed kinase assays on whole extracts of the same transfected cells. As expected and already observed for the untagged a protein ( Figure 1A ), overexpression of CK2a-HA led to a strong (10-fold) increase in CK2 activity. In contrast, cells expressing CK2a-K68A exhibited the same level of CK2 activity as the control cells transfected with the empty vector (Figure 2c ).
Effect of overexpression of the CK2 kinase-inactive mutant on BrdU incorporation
We then analysed the eect of the CK2a-K68A mutant overexpression on cell proliferation by BrdU analysis. When using epitope-tagged proteins, one cannot completely exclude the possibility that the tag interferes Figure 1 Transient overexpression of isolated a, a' or b CK2 subunits has no eect on NIH3T3 ®broblast proliferation. NIH3T3 cells were transiently transfected by the calcium phosphate procedure with the pEGFP plasmid together with the pSG5 control vector or the following pSG5 constructs: the MAP kinase phosphatase Pyst-1-HA, CK2a, CK2a', CK2b. (A) Overexpression of a, a', or b subunits in NIH3T3 cells. At 56 h after transfection, the cells were harvested, cell lysates prepared, and expression of a, a', and b CK2 subunits was examined by immunoblotting using anti-CK2a (upper blot) or anti-CK2b (lower blot) antibodies. (B) CK2 activity in transfected cells. CK2 activities in crude cell lysates were determined using a CK2-speci®c peptide substrate RRREDEESDDEE. The experiment is representative of three independent experiments and mean values+s.d. from triplicate assays are reported. (c) BrdU incorporation in GFP (+) cells. Cells were rendered quiescent for 25 h (by serum-deprivation) and stimulated for 19 h with 10% FCS the BrdU being added for the last 3 hours. The transfected cell population was identi®ed by GFP¯uorescence. GFP (+) cells were examined for BrdU incorporation. BrdU (+) cells were identi®ed using indirect immuno¯uorescence (monoclonal antiBrdU antibody). BrdU (+) / GFP (+) cells represents the fraction of GFP (+) cells with active DNA synthesis with speci®c functions of the analysed protein. We therefore decided to use plasmids encoding untagged forms of CK2a or CK2a-K68A in proliferation experiments.
We ®rst examined the expression of the kinasede®cient mutant in NIH 3T3 cells. As illustrated in Figure 3A , the level of expression of the kinase-inactive mutant was similar to that of the wild-type protein.
In cells stimulated with FCS for cell cycle reentry after synchronization by FCS-deprivation, the kinasede®cient CK2a mutant induced a marked inhibition of BrdU incorporation (50 to 70% of inhibition) ( Figure  3B ). This inhibition was not due to an eect of the mutant expression on cell viability as demonstrated using¯ow cytometry analysis on the GFP (+) cell population (data not shown).
This inhibitory eect was also observed when BrdU incorporation was monitored in an asynchronous population of cycling cells ( Figure 3C ). NIH3T3 cells were transfected with increasing amounts of plasmid encoding a or a-K68A CK2 subunits. The expression levels of the kinase-de®cient mutant obtained upon transient transfection were dose-dependent and comparable to those obtained upon transfection of the wild-type CK2a (data not shown). Consistent with the nature of a dominant-negative eect, a marked overexpression of the kinase-de®cient mutant was required to promote its inhibitory action.
Figure 2 CK2 kinase activity in NIH3T3 cells expressing HA-tagged CK2a or CK2a-K68A subunits. NIH3T3 cells were transiently transfected by the lipofectamine procedure with the pSG5 control vector or the following pSG5 constructs: CK2a -HA, CK2a-K68A-HA. Cell lysates were prepared and used for immunoblotting to examine overexpression of HA-tagged CK2a and CK2a-K68A subunits with anti-CK2a antibody as well as expression of endogenous CK2b with the bc antibody (A). CK2 speci®c activity was measured as described in the legend of Figure From these results we conclude that CK2 appears to play an important role in the G1/S progression of cell cycle in NIH3T3 ®broblasts.
The CK2 kinase-negative mutant is capable of recruiting endogenous CK2b to form inactive tetramers To understand how this CK2a kinase-inactive mutant exerts a dominant-negative eect on CK2 functions, we analysed whether it had retained its capacity to bind CK2b with high anity.
NIH3T3 cells were transiently transfected with HAtagged CK2a wild-type or CK2a-K68A mutant. The same level of expression was obtained for both proteins ( Figure 4A , lanes 2 and 3). Endogenous CK2b was immunoprecipitated from cell lysates with the antiCK2b : bc antibody (equal amounts of CK2b were recovered, Figure 4A lower panel), and the bc immunoprecipitates were then probed by immunoblotting with the 12 CA5 antibody ( Figure 4A upper panel). The kinase-de®cient mutant was as ecient as the wild-type CK2a subunit in recognizing and associating with the endogenous b subunit.
To ensure that exogenous CK2 a-K68A was associated with endogenous CK2b in a tetrameric complex, we analysed NIH3T3 cell lysates transiently transfected with an HA-tagged form of CK2a-K68A by gel ®ltration. Fractions were collected and CK2 activity assay as well as Western blot analysis (anti-HA) were done on these fractions ( Figure 4B ). Immunoblot analysis with the anti-HA antibody revealed the presence of the CK2a-K68A-HA protein in two sets Figure 3 Overexpression of a kinase-inactive mutant of CK2a: CK2a-K68A inhibits NIH3T3 cell proliferation. NIH3T3 cells were transiently transfected by the calcium phosphate procedure with the pEGFP plasmid together with the pSG5 control vector or the following pSG5 constructs: Pyst-1-HA, CK2a, CK2a-K68A. (A) Overexpression of a, or a-K68A subunits in NIH3T3 cells. At 56 h after transfection, the cells were harvested, cell lysates prepared, and expression of a, and a-K68A CK2 subunits was examined by immunoblotting using anti-CK2a antibodies. (B) Eect of overexpression of the CK2a-K68A mutant on G1/S progression. BrdU incorporation was measured in GFP (+) cells after synchronization by serum-deprivation as described in the legend of Figure 1C . (C) Dose-response eect of overexpression of the CK2a-K68A mutant on BrdU incorporation in an asynchronous population of cycling NIH3T3 ®broblasts. NIH3T3 cells were transiently transfected by the calcium phosphate procedure with the pEGFP plasmid together with increasing amounts of either wild type pSGa (open bars) or the mutant pSGa-K68A (solid bars). After transfection, the cells were left in 10% FCS DMEM for 24 h with a pulse of BrdU for the last 3 h. BrdU incorporation was measured in GFP (+) cells as described in the legend of Figure 1C . The results represent determinations for one experiment that is representative of two independent experiments A dominant-negative mutant of CK2 inhibits cell proliferation F Lebrin et al of fractions: the ®rst one corresponding to an apparent molecular mass of the tetrameric form of CK2: a 2 b 2 (145 000 Da) and was associated with a peak of CK2 speci®c activity, the second one corresponding to the apparent molecular mass of the CK2a subunit (45 000 Da) exhibited no catalytic activity. Important conclusions can be drawn from this experiment: in NIH3T3 cells transfected with the Figure 4 Exogenous CK2a-K68A is capable of recruiting endogenous CK2b to generate a population of inactive tetramers. (A) NIH3T3 cells were transiently transfected by the lipofectamine procedure with the pSG5 control vector or the following pSG5 constructs: CK2a-HA, CK2a-K68A-HA. Cells were harvested, cell lysates prepared and immunoprecipitation of endogenous CK2b was performed using bc antibody. Upper panel, 12CA5 immunoblot on total cell extracts (lanes 1, 2 and 3) revealed that CK2a -HA and CK2a-K68A-HA were indeed expressed. Lanes 4, 5 and 6: 12CA5 immunoblot of bc immunoprecipitates showing coimmunoprecipitation of both exogenous CK2a -HA and CK2a-K68A-HA with endogenous CK2b. Lower panel, anti CK2b (bc) immunoblot of the same samples as in the upper panel. (B) Gel ®ltration analysis on NIH3T3 cell extracts from cells that have been transfected with pSGa-K68A-HA. Two-ml fractions were collected and were assayed for CK2 speci®c activity using the peptide substrate (upper panel) and analysed for CK2a-K68A-HA expression by 12CA5 immunoblotting (lower panel). The elution position and molecular mass (in Da) of standard proteins the void volume (V 0 ) and the total volume (V t ) of the Sephacryl column are indicated in the upper part Oncogene A dominant-negative mutant of CK2 inhibits cell proliferation F Lebrin et al kinase-de®cient mutant, pools of b-free CK2aK 7 and of mutant integrated in tetrameric forms of CK2: aK 7 2 b 2 or aaK 7 b 2 can be detected. The association of aK 7 with endogenous wild-type a through the tetramer explains the presence of a CK2 activity peak in the tetrameric fraction; this result is consistent with the low levels of kinase activity we observed in 12CA5 immunoprecipitates prepared from CK2a-K68A-HA transfected cells ( Figure 2B ). We have therefore demonstrated that the kinase-de®cient mutant is capable of`trapping' endogenous CK2b to form an inactive tetrameric form of CK2 thereby exerting a dominant-negative eect on CK2 cellular functions.
The exogenous CK2a-K68A mutant is expressed to signi®cantly higher levels than the endogenous wildtype protein and is capable of binding CK2b. Moreover, overexpression of the aK-mutant does not induce overexpression of CK2b (Figure 2A ). We therefore hypothesized that the kinase-inactive mutant could exert a dominant-negative eect through the titration of the available endogenous regulatory CK2b subunit. We then analysed the eect of simultaneous overexpression of both CK2a-K68A and CK2b on BrdU incorporation in NIH3T3 cells. Figure 5A illustrates the levels of expression for CK2a-K68A and CK2b subunits obtained using the usual calcium-phosphate transfection procedure. Cotransfection of pSGb with pSGa-K68A did not alter the level of expression of the CK2a-K68A mutant. As shown in Figure 5B , the presence of overexpressed CK2b subunit did not reverse the inhibition of G1/S progression induced by the kinase-de®cient mutant indicating that titration of endogenous CK2b cannot account for the eect of the kinase-inactive mutant.
Overexpression of the a kinase-inactive mutant does not generate a significant population of b-free CK2a
Since the a kinase-inactive mutant is able to replace a in the CK2 tetramer, we examined whether overexpression of the kinase-de®cient mutant would lead to generation of a signi®cant CK2b-free pool of CK2a through a displacement process. To test this hypothesis, we compared the eect of overexpression of HAtagged CK2a and CK2a-K68A on phosphorylation of a speci®c monomeric CK2a substrate: calmodulin which phosphorylation is inhibited by the presence of CK2b (Bidwai et al., 1993; Meggio et al., 1994) . As illustrated in Figure 6A , similar levels of overexpression of HA-tagged CK2a and CK2a-K68A subunits were obtained in NIH3T3 cells. Cell lysates were incubated with [g 32 P]-ATP and phosphorylated calmodulin was detected by autoradiography of the products separated on SDS ± PAGE. As shown in Figure 6b , when cells were transfected with the empty vector no phosphorylation of calmodulin could be detected. This demonstrates the absence of a CK2b-free population of endogenous CK2a in cell lysates. In contrast, as expected, lysates from cells overexpressing CK2a-HA were capable of phosphorylating calmodulin to a signi®cant extent. Lysates from cells overexpressing CK2a-K68A-HA appeared unable to phosphorylate calmodulin. Consistent with the results shown in Figure 5 , these ®ndings do not argue in favor of the generation of a signi®cant population of free CK2a by expression of the a kinase-de®cient mutant. Figure 5 Co-expression of CK2b with the kinase-inactive mutant CK2a-K68A does not reverse its inhibitory eect on cell proliferation. NIH3T3 cells were transiently transfected by the calcium phosphate procedure with the pEGFP plasmid together with the pSG5 control vector or the following pSG5 constructs: CK2a-K68A, or CK2a-K68A+CK2b. (A) Overexpression of CK2a-K68A, or CK2a-K68A+CK2b subunits in NIH3T3 cells. At 56 h after transfection, the cells were harvested, cell lysates prepared, and expression of a-K68A, and b CK2 subunits was examined by immunoblotting using anti-CK2a (upper blot) or anti-CK2b (lower blot) antibodies. (B) Eect of overexpression of the CK2a-K68A mutant on G1/S progression. BrdU incorporation was measured in GFP (+) cells after synchronization by serum-deprivation as described in the legend of Figure 1C Overexpression of the a kinase-inactive mutant results in decreased phosphorylation of associated CK2b
To show that overexpression of the kinase-inactive mutant interfered with the phosphorylation of an endogenous CK2 substrate, we used lysates from NIH3T3 cells overexpressing HA-tagged CK2a or CK2a-K68A ( Figure 6A ) in order to perform anti-HA immunoprecipitations. The immunoprecipitates were incubated in the presence of [g 32 P]-ATP. Phosphorylation patterns are illustrated in Figure 6C (right panel). Whereas the same amount of CK2b was recovered through coprecipitation with HA-tagged CK2a and CK2a-K68A ( Figure 6C left panel) , its Figure 6 Overexpression of the a kinase-inactive mutant results in decreased phosphorylation of associated CK2b and does not generate a signi®cant population of b-free CK2a. NIH3T3 cells were transiently transfected by the lipofectamine procedure with the pSG5 control vector or the following pSG5 constructs: CK2a-HA, CK2a-K68A-HA. (A) Cell lysates were prepared and used for immunoblotting to examine overexpression of HA-tagged CK2a and CK2a-K68A subunits as well as expression of endogenous CK2b subunit. (B) Total cellular extracts were used in phosphorylation assays using calmodulin as a speci®c CK2 catalytic subunit substrate. The reaction products were run on SDS-polyacrylamide gel electrophoresis and the blots were autoradiographed using a phosphorimager (Molecular Dynamics). (C) Right panel, HA-tagged CK2a and CK2a-K68A were immunoprecipitated with 12CA5 antibody and the immunoprecipitates were incubated in the presence of [g 32 P]-ATP without exogenous substrate. Phosphoproteins were detected after SDS ± PAGE (12%) by autoradiography using a phosphorimager. Left panel, immunoblotting of the same samples as in right panel, with the anti-CK2a antibody showed that the same amount of CK2b was indeed immunoprecipitated from pSG a-HA and pSG a-K68A-HA immunoprecipitates Oncogene A dominant-negative mutant of CK2 inhibits cell proliferation F Lebrin et al phosphorylation state was greatly diminished when associated with the kinase-inactive mutant.
Stable expression of the CK2a-K68A mutant in PS120 fibroblasts inhibits cell proliferation Since transient overexpression of the a kinase-inactive mutant interferes with G1/S progression, we performed ow cytometry analysis in order to examine whether later phases of the cell cycle were also aected. This type of experiment on transiently-transfected cells requires cotransfection of the plasmid encoding the GFP protein and cell cycle analysis to be done on the selected GFP (+) cells. The results were not conclusive enough. To circumvent the diculties inherent to transient expression, we decided to generate stable clones overexpressing the CK2a-K68A mutant. For this purpose, NIH3T3 cells were transfected with the pLXSN expression vector containing linked CK2a-K68A and Neo r genes : pLXSN-CK2a-K68A-HA. After G418 selection, no stable clones expressing the kinase-inactive mutant could be isolated. We used PS120 cells: a Na + /H + exchanger-de®cient derivative of the Chinese hamster lung ®broblast CCL39 cell line that allows a dierent selection strategy (Pouyssegur et al., 1984) . Co-transfection of the plasmid encoding the Na + /H + exchanger NHE1 (pEAP 7 plasmid) with the plasmid encoding the protein of interest allows selection of the transfected cells using the H + suicide procedure (Wakabayashi et al., 1992) .
We ®rst analysed whether transient overexpression of the CK2a kinase-inactive mutant, as in NIH3T3 cells, inhibits BrdU incorporation in PS120 cells. We did the same type of experiment as described for NIH3T3 cells in Figure 3 . As shown in Table 1 , overexpression of the a-K68A mutant indeed had an inhibitory eect (40%) on G1/S progression in PS120 cells.
To obtain stable cell lines overexpressing the CK2a kinase-negative mutant, PS120 cells were transfected with the Na + /H + exchanger expression pEAP 7 plasmid together with the pSG5 vector alone or the vector containing CK2a-K68A cDNA. Clonal cell lines expressing CK2a-K68A or empty vector were selected by the H + suicide procedure. We observed that expression of the kinase-inactive mutant signi®cantly reduced cloning eciency (by 50%) consistent with an inhibitory eect of this mutant on PS120 cell growth (data not shown). Western blot analysis was done on the selected PS120 clones. A number of clones did not show any signi®cant expression of the CK2a-K68A mutant, however, two clones exhibited a marked expression of the kinase-negative mutant: aK 7 4 and aK 7 12 ( Figure 7A ). Interestingly, anti-CK2b immunoblots demonstrated that these two clones also exhibited a slight overexpression of CK2b. We ensured that stable overexpression of the kinase-inactive mutant did not induce overexpression of endogenous CK2a by performing kinase assays of CK2 activity on the synthetic peptide: no dierence was detected in CK2 activity for the aK 7 4 and aK 7 12 clones as compared to PS120 cells were transiently transfected by the calcium phosphate procedure with the pEGFP plasmid together with the pSG5 control vector of the following pSG5 constructs: Pyst-1-HA, CK2a, CK2a-K68A. BrdU incorporation was measured in GFP (+) cells stimulated for cell cycle re-entry after synchronization by serumdeprivation as described in the legend of Figure 1C . BrdU (+)/GFP (+) cells represent the fraction of GFP (+) cells with active DNA synthesis Figure 7 Stable expression of the CK2a-K68A mutant in PS120 ®broblasts inhibits cell proliferation. (A) PS120 cells were transfected as described under Materials and methods with the Na + /H + exchanger pEAP 7 selection plasmid together with either the pSG5 control vector or the pSG5 construct encoding the CK2 a-K68A mutant (pSGaK 7 ). Stable clones were selected using the H + suicide selection and were examined for expression of CK2a-K68A and CK2b using respectively anti-CK2a and anti-CK2b antibodies. (B) Stable clones expressing the control vector (pSG5) or CK2a-K68A (aK 7 2, aK 7 4, aK 7 12 clones) were plated at low density in six-well dishes (10 000 cells / well) and cultured in 5% FCS medium for 5 days. Cell proliferation was examined by cell counting every 24 hours. The results represent the average of duplicate determinations for one experiment that is representative of three independent experiments the cells transfected with the empty vector (data not shown).
Growth curves were done on four stably transfected cell lines ( Figure 7B ). Overexpression of CK2a-K68A induced a signi®cant decrease in the rate of proliferation of the transfected PS120 cells : two-to fourfold decrease in proliferation over the time course. In contrast, as expected, CK2a-K68A transfectants showing no expression of the mutant (aK 7 2 clone) had a normal growth rate as compared with the vector control.
Flow cytometry analysis was done on the four cell lines to con®rm that this decrease in the growth rate resulted from cell cycle perturbations. FACS pro®les were determined on cells stimulated with serum for cell cycle re-entry after synchronization by serum-deprivation. Both pSG5 and aK 7 2 clones exhibited similar FACS pro®les. In contrast, the clones overexpressing the a-K68A mutant (aK 7 4 and aK 7 12 ) exhibited a higher percentage of cells in G1 phase (50% increase) con®rming on stable clones an eect of the kinasede®cient mutant on G1/S progression (data not shown).
Discussion
The most convincing data concerning the role of protein kinase CK2 in the control of cell growth and cell cycle progression have been obtained in yeast (reviewed in Glover, 1998) . In particular, in Saccharomyces cerevisiae, a major role of CK2 in cell proliferation has been unambiguously demonstrated by elegant molecular genetic studies (Hanna et al., 1995; Padmanabha et al., 1990) .
In mammalian cells discrepancies in the reported results prevent unequivocal conclusions (Heriche et al., 1997; Li et al., 1999; Lorenz et al., 1999; Lorenz et al., 1993; Orlandini et al., 1998; Pepperkok et al., 1991; Ulloa et al., 1993; Vilk et al., 1999) . Many studies tried to show an increase in CK2 activity upon stimulation with growth factors but the validity of these results has been questioned due to a lack of reproducibility (Litch®eld et al., 1994) .
Pyerin's group has used microinjection of antibodies against CK2b or exposure to anti-a and anti-b antisense to assess the role of CK2 in proliferation in IMR-90 ®broblasts (Lorenz et al., 1993; Pepperkok et al., 1994) . Unfortunately, direct evidence of the eect of the antisense on expression of the CK2 subunits was not reported. More recently, the same authors further investigated the role of CK2 in proliferation initiation using microinjection of antibodies against CK2 catalytic subunits and of substrates and non-substrates peptides (Lorenz et al., 1999) . Interestingly, they demonstated that the catalytic subunits appear to be involved not only via phosphorylation(s) but also via non-phosphorylation protein ± protein interactions. Interference of CK2 with signaling pathways through interaction with speci®c partners has also been established: in NIH3T3 ®broblasts, CK2a was shown to bind protein phosphatase 2A and interfere with the MAP kinase pathway (Heriche et al., 1997; Lebrin et al., 1999) ; in Xenopus oocytes, binding of CK2b to Mos represses Mos-mediated MAP kinase activation and interferes with Xenopus oocyte maturation (Chen et al., 1997) .
In the present study, we have analysed the role of CK2 in proliferation using two ®broblast cell lines. Using transient (in NIH3T3 cells) and stable (in CCL39 cells) transfection experiments we have analysed the eects of overexpression of wild-type or mutated CK2 individual subunits on proliferation and cell cycle progression.
We ®rst analysed the eects of overexpression of CK2a, a' or b subunits on NIH3T3 proliferation using BrdU incorporation measurements. We successfully achieved overexpression of each isolated subunit with no eect on expression of the others. Despite a very substantial level of overexpression achieved for each of the three proteins, we failed to observe any eect of this overexpression on cell proliferation. Increased expression of either catalytic CK2 subunit : a or a' is expected to result in an increased phosphorylation of CK2 target proteins; if this is the case, it does not interfere with cell proliferation. A recent study has reported that ectopic expression of Myc-tagged CK2b resulted in growth inhibition (Li et al., 1999) . Our results diverge from this observation. The reasons for this discrepancy are unclear. Two explanations may account for it. First, the cell lines used in this study are dierent from the ones we used: Chinese Hamster Ovary cells and 3T3 L1 ®broblasts versus NIH3T3 and CCL39 ®broblasts. Second, the levels of expression achieved in the two studies are dierent. In their study on clones stably expressing Myc-CK2b, Li et al. (1999) were unable to detect expression of exogenous MycCK2b protein by immunoblotting on crude cell lysates: it is rather puzzling that such a very small amount of exogenously expressed Myc-CK2b protein had such a signi®cant eect on cell growth.
We then chose to investigate the eects of`neutralizing' protein kinase CK2 on proliferation. Our strategy was to overexpress a catalytically-inactive mutant of CK2a subunit anticipating that it could play a dominant negative role towards CK2 by interfering with its cellular functions (Cosmelli et al., 1997) . Our data showed that the overexpression of the mutant results in a signi®cant inhibition of BrdU incorporation (450%) in cells stimulated for cell cycle re-entry after synchronization by serum-deprivation as well as in a population of asynchronous cells. To understand the mechanism by which the kinase-dead mutant exerts a dominant-negative eect on CK2 functions, we analysed its behaviour towards the endogenous pool of CK2 subunits. The regulatory subunit b is responsible for the building of the a 2 b 2 tetramers (Chantalat et al., 1999) . It was therefore important to check that the a kinase-inactive mutant is capable to recruit endogenous CK2b to generate a population of inactive tetramers. Immunoprecipitation and gel ®ltra-tion analysis clearly showed that it is the case. CoOncogene A dominant-negative mutant of CK2 inhibits cell proliferation F Lebrin et al immunoprecipitation of a kinase-inactive mutant with endogenous CK2b has also been observed by two other groups : CK2a-K68M mutant in an osteosarcoma cell line (Penner et al., 1997; Vilk et al., 1999) ; CK2a-Asp156Ala mutant in Cos-7 cells (Cosmelli et al., 1997; Korn et al., 1999) . Gel ®ltration experiments allowed us to demonstrate that in the aK68A-transfected cells, a population of free aK 7 subunit together with a population of inactive tetramers coexisted while no increase in the expression of endogenous b concomittant to the overexpression of the aK 7 mutant could be detected. The amount of endogenous CK2b available is therefore limited. CK2b exerts a regulatory function towards the catalytic a or a' subunits; moreover, CK2b interacts and regulates other Ser/Thr kinases than CK2a or a' : A-Raf (Boldyre and Issinger, 1997; Hagemann et al., 1997) and Mos (Chen et al., 1997) . The amount of endogenous CK2b available being limited, it could be hypothesized that the CK2a-K68A mutant acts as a dominant negative mutant towards CK2b functions independently of CK2 kinase activity. However, it may not be the case since there was no rescue of the inhibitory eect of the kinase-de®cient mutant on proliferation by the cotransfection of CK2b.
Overexpression of the CK2a kinase-negative mutant does not generate a major population of free CK2a since we could not detect any phosphorylation of calmodulin ± a substrate speci®c of CK2a versus CK2a 2 b 2 ± in cells transfected with CK2a-K68A-HA.
The dominant-negative eect of the kinase-negative mutant expression was demonstrated on the phosphorylation of CK2b which is the major substrate associated with CK2a-HA or CK2a-K68A-HA. Although it does not completely abolish the activity of the endogenous CK2a, expression of the kinasenegative mutant probably interferes with phosphorylation of CK2 target proteins; optimal phosphorylation of these substrates by CK2 appears to be required to achieve optimal cell cycle progression.
Some of the discrepancies in the data from the literature on the role of CK2 in cell proliferation may also be explained by the use of dierent cell types. It was therefore important to con®rm our results on another cell line. This was achieved using the CCL39-derivative PS120 cells. Interestingly, in contrast to transient expression experiments, long term expression of the kinase-inactive a mutant in stable PS120 clones stimulates, to a certain extent, the expression of endogenous CK2b. In agreement with the results of the experiments of coexpression of CK2b with the CK2a-K68A mutant, we still observed the inhibitory eect of the kinase-inactive mutant on proliferation in the stable PS120 clones. In the only study using expression of kinase-inactive mutants of CK2 catalytic subunits to explore the role of CK2 in cell proliferation, Vilk et al. (1999) reported that induction of a kinase-inactive mutant of CK2a' : a'-K69M resulted in a dramatic attenuation of proliferation whereas induction of a kinase-inactive mutant of CK2a : a-K68M had no eect. Our results are not in agreement with this report. Several points are worth mentioning regarding this study. It was done using a transformed cell line: a human osteosarcoma; the level of induction of the dierent CK2 subunits was low in comparison with the levels obtained in our study: only 2 ± 3-fold increase in CK2 activity following induction of CK2a or CK2a' compared to 10 ± 20-fold in our report. Moreover, unexpectedly induction of the wild-type protein CK2a' also induced inhibition of cell growth (50%) (although to a lesser extent than the kinaseinactive a' mutant). In our study, we did not observe any eect of CK2a' overexpression on proliferation. Finally, the authors could not link the eect on growth with defects in cell cycle since no signi®cant alteration in cell cycle was detected following induction of the kinase-negative a' mutant. This is in contrast with our results; using BrdU incorporation and¯ow cytometry, we clearly demonstrated that the growth inhibition observed in the CCL39 cells overexpressing the kinaseinactive mutant indeed resulted from defects in cell cycle progression.
In conclusion, using a dominant-negative approach by overexpressing a kinase-inactive mutant of CK2 catalytic subunit a, we have shown that protein kinase CK2 plays an important role in cell cycle progression in mammalian ®broblasts.
Materials and methods

Plasmids
The plasmids encoding the dierent CK2 subunits untagged or C-terminally tagged with the HA epitope have been previously described (Heriche et al., 1997) . The pEGFP plasmid was purchased from CLONTECH. The plasmid encoding Pyst1-HA was a kind gift from SM Keyse and was described previously (Groom et al., 1996) .
Antibodies
Polyclonal anti-CK2b (bc) antiserum directed against the 12 carboxy terminal amino acid (204 ± 215) sequence of the Drosophila CK2b subunit and polyclonal anti-CK2a antiserum directed against the Drosophila CK2a subunit have been described previously (Egyhazi et al., 1999; Filhol et al., 1991) . The monoclonal antibody 12CA5 which recognizes the HA epitope was from BabCO.
Cell culture and transfections
NIH3T3 and PS120 cells were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum (Life Technologies Inc.) at 378C in an atmosphere of 95% air, 5% CO2. PS120 cells are Na + /H + antiporter-de®cient mutants derived from the CCL39 cell line by the H + suicide method (Pouyssegur et al., 1984) .
For transient transfections, the cells were transfected using either the standard calcium phosphate coprecipitation method (transfection eciency : 30%) or the lipofectamine (Life Technologies Inc.) reagent according to the manufacturer's instructions (transfection eciency: 70 ± 80%).
For stable transfections, PS120 cells were cotransfected by the calcium phosphate coprecipitation technique with 2 mg of pEAP 7 expression vector encoding the Na + /H + antiporter (Sardet et al., 1989; Wakabayashi et al., 1992) and 18 mg of the relevant plasmid construct. The transfected cells were selected after three consecutive tests of intracellular pH recovery after cytoplasmic acidi®cation (H + suicide selection) as described previously (Wakabayashi et al., 1992) .
Kinase assays
CK2 activity was assayed by incubating immunoprecipitateor lysate-aliquots from NIH3T3 cells in 30 ml kinase buer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 20 mM MgCl 2 , 50 mM [g 32 P]-ATP (1 ± 2 mCi/reaction) at 308C for 7 min using the synthetic RRREDEESDDEE peptide (150 mM) as a substrate. Incorporated radioactivity was determined using the phosphocellulose paper method as previously described (Egyhazi et al., 1999) . When calmodulin was used as a substrate (10 mM), the concentrations of NaCl and MgCl 2 were respectively of 50 mM and 10 mM. For CK2b autophosphorylation experiments, immunoprecipitated CK2 was incubated in the kinase buer containing 50 mM [g 32 P]-ATP (10 mCi/reaction) for 30 min. For calmodulin and CK2b autophosphorylation experiments, proteins were solubilized by boiling in Laemmli sample buer. Samples were analysed by SDS ± PAGE on 12/14% polyacrylamide gels. Phosphoproteins were visualized by autoradiography.
BrdU incorporation and immunofluorescence
Cells were plated onto glass coverslips at the density of 600 000 cells/ 60 mm dish (NIH3T3 cells) or 250 000/60 mm dish (PS120 cells). They were co-transfected by the calcium phosphate technique with pEGFP (1 mg) and 8 mg of the relevant constructs. After 12 h-transfection, the cells were either rendered quiescent by incubation in serum-free medium for 25 h and then stimulated for 19 h with 10% FCS, with a pulse of BrdU (50 mM) for the last 3 h (G1/S phase experiments) or left in DMEM 10% FCS for 24 h with a pulse of BrdU (50 mM) for the last 3 h (experiments on asynchronous cycling cells). The cells were then ®xed in 4% paraformaldehyde for 20 min at room temperature, rinsed in PBS and the chromatine was rendered accessible by a 30 min treatment with HCl (2N). Cells were extensively washed with PBS and the non-speci®c sites were blocked by incubation with PBS+3% BSA. The cells were incubated with the anti-BrdU monoclonal antibody (SIGMA; 1/1000) for 1 h, then washed with PBS+0.1% Tween 20 and ®nally incubated with a secondary antibody: goat anti-mouse cyanine-conjugated antibody (Jackson Immunotech; 1/500). The coverslips were mounted in citi¯uor. The proportion of BrdU (+) / GFP (+) cells was determined by analysing at least 100 GFP (+) cells in 10 ± 15 ®elds for each transfection done in triplicate, in at least three independent experiments.
Gel filtration
A Sephacryl S-200 gel ®ltration column was calibrated by using cytochrome C (M r =13000 Da), Bovine Serum Albumin (M r =68000 Da), dextran blue (M r =2 10 6 Da) as standards. Lysates from NIH3T3 cells transfected with pSGa-K68A-HA using the lipofectamine procedure were applied to the column equilibrated in 10 mM Tris-HCl pH 7.4, 1 mM dithiothreitol, 2% glycerol, 500 mM NaCl. 2 ml-fractions were collected and anti-HA immunoblot analysis and CK2 activity assays were performed on them.
Immunoprecipitation
Cells were washed twice in PBS and extracted in lysis buer: 50 mM Tris-HCl pH 7.5; 500 mM NaCl; 5 mM EDTA; 1% Triton X-100, AEBSF (0.5 mM), leupeptin (2 mg/ml), aprotinin (2 mg/ml). Lysates were cleared by centrifugation at 14 000 r.p.m. for 10 min at 48C; the protein concentration was determined and equal amounts of lysates were subjected to immunoprecipitation. Lysates were incubated with either 12CA5 or bc antibodies for 2 h then 40 ml of 50% protein Asepharose (Amersham Pharmacia Biotech.) was added to the mixture for another hour. Protein A-sepharose beads were washed ®ve times in lysis buer and immunoprecipitated proteins were either solubilized by boiling in Laemmli sample buer for subsequent analysis by SDS ± PAGE and Western blotting, or used for kinase assays.
Immunoblotting
Cells were washed twice in ice-cold PBS and lysed in Triton buer : 50 mM Tris-HCl pH 7.5; 500 mM NaCl; 5 mM EDTA; 1% Triton X-100, AEBSF (0.5 mM), leupeptin (2 mg/ml), aprotinin (2 mg/ml).
Lysates were cleared by centrifugation at 14 000 r.p.m. for 10 min at 48C; the protein concentration was determined and proteins from equal amounts of lysates were separated by 12 or 14% SDS ± PAGE. Proteins were transferred to nitrocellulose. Incubation with primary antibodies was followed by incubation with horseradish peroxidase-conjugated secondary antibodies; immune complexes were then detected with the enhanced chemiluminescence immunodetection system (Dupont NEN).
Growth curves
The growth rate of stable clones of transfected PS120 cells was measured by counting the number of cells after cells were plated. Cells were seeded at a density of 10 000 cells/35-mm well in 5% FCS DMEM, with duplicate wells for each cell line. Every 24 h, the cells were trypsinized and counted using a cell counter (Coultronics).
Autoradiograms are representative of at least three separate experiments. Data are presented as the mean+s.d. of at least three independent experiments performed in triplicate.
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